These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34198110)

  • 1. Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.
    Mulakavalupil B; Vaity C; Joshi S; Misra A; Pandit RA
    Diabetes Metab Syndr; 2021; 15(4):102169. PubMed ID: 34198110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
    Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
    Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
    Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
    J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of COVID-19 patients with prediabetes.
    Chandrasekaran ND; Velure Raja Rao MR; Sathish T
    Diabetes Metab Syndr; 2021; 15(4):102192. PubMed ID: 34224947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
    Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients.
    Giraudo C; Librizzi G; Fichera G; Motta R; Balestro E; Calabrese F; Carretta G; Cattelan AM; Navalesi P; Pelloso M; Plebani M; Rea F; Vettor R; Vianello A; Stramare R
    PLoS One; 2021; 16(6):e0253433. PubMed ID: 34138945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between abdominal CT findings in intensive care unit (ICU) and non-ICU patients with Covid-19: experience from a tertiary care hospital.
    Goyal H; Sureka B; Mangaraj N; Agarwal A; Kothari N; Garg MK; Banerjee M; Agarwal A; Garg P; Yadav T; Khera P
    Afr Health Sci; 2023 Dec; 23(4):64-74. PubMed ID: 38974306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
    Raut A; Huy NT
    Lancet Respir Med; 2021 Aug; 9(8):e77. PubMed ID: 34090607
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-infectious and post-acute sequelae of critically ill adults with COVID-19.
    Ibrahim H; Athar S; Harhara T; Elhag SA; MElnour S; Sukkar HH; Kamour AM
    PLoS One; 2021; 16(6):e0252763. PubMed ID: 34138871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Control and Mucormycosis during COVID-19 Pandemic in India a Study of Stage and Outcome.
    Sharma V; Kriplani K; Tuli IP; Sharma S; Narula A
    J Assoc Physicians India; 2023 Sep; 71(9):61-66. PubMed ID: 38700303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit.
    Jeitziner MM; Jenni-Moser B; Yok-Ai Q; Thurnheer Zürcher MC; Furrer H; Jakob S
    Swiss Med Wkly; 2021 Jun; 151():w20529. PubMed ID: 34233009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing.
    Izquierdo JL; Ancochea J; ; Soriano JB
    J Med Internet Res; 2020 Oct; 22(10):e21801. PubMed ID: 33090964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
    Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
    Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Profile of Mucormycosis Patients during Coronavirus Disease 2019 Pandemic: A Retrospective Observational Study.
    Gondane B; Jain SK; Dube S
    J Assoc Physicians India; 2024 Mar; 72(3):27-31. PubMed ID: 38736113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological association of mucormycosis in COVID 19 pandemic.
    Varshney M; Saxena A; Binnani N; Kumar V; Vyas SP
    Indian J Pathol Microbiol; 2023; 66(1):101-105. PubMed ID: 36656219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.